2,034 Shares in Teleflex Incorporated (NYSE:TFX) Purchased by Blueshift Asset Management LLC

Blueshift Asset Management LLC acquired a new stake in shares of Teleflex Incorporated (NYSE:TFX - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,034 shares of the medical technology company's stock, valued at approximately $362,000.

A number of other institutional investors have also recently made changes to their positions in TFX. Janus Henderson Group PLC increased its position in Teleflex by 2.8% during the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company's stock valued at $1,329,704,000 after purchasing an additional 147,147 shares during the period. State Street Corp boosted its stake in Teleflex by 1.0% in the 3rd quarter. State Street Corp now owns 2,057,080 shares of the medical technology company's stock worth $508,757,000 after purchasing an additional 21,291 shares in the last quarter. Geode Capital Management LLC grew its position in Teleflex by 0.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company's stock valued at $278,676,000 after purchasing an additional 5,746 shares during the last quarter. Cooke & Bieler LP increased its stake in Teleflex by 22.1% during the 4th quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company's stock valued at $191,962,000 after purchasing an additional 195,150 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA boosted its position in shares of Teleflex by 0.4% during the third quarter. Massachusetts Financial Services Co. MA now owns 427,579 shares of the medical technology company's stock valued at $105,749,000 after buying an additional 1,884 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

Several research firms have issued reports on TFX. Bank of America cut shares of Teleflex from a "neutral" rating to an "underperform" rating and lowered their target price for the company from $235.00 to $140.00 in a research note on Tuesday, March 4th. StockNews.com cut shares of Teleflex from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Royal Bank of Canada downgraded shares of Teleflex from an "outperform" rating to a "sector perform" rating and cut their target price for the stock from $220.00 to $155.00 in a research report on Friday, February 28th. Piper Sandler reissued a "neutral" rating and set a $140.00 price target (down from $255.00) on shares of Teleflex in a report on Friday, February 28th. Finally, Wells Fargo & Company cut their price objective on Teleflex from $214.00 to $146.00 and set an "equal weight" rating for the company in a report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $182.63.

Teleflex Stock Performance

Shares of NYSE:TFX traded up $0.88 during mid-day trading on Wednesday, reaching $140.13. 747,532 shares of the company traded hands, compared to its average volume of 552,531. The company's 50 day moving average price is $161.64 and its 200-day moving average price is $192.23. The firm has a market cap of $6.50 billion, a PE ratio of 27.86, a PEG ratio of 1.73 and a beta of 1.21. Teleflex Incorporated has a 52 week low of $128.55 and a 52 week high of $249.91. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating the consensus estimate of $3.86 by $0.03. The business had revenue of $795.40 million for the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. On average, equities analysts expect that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were issued a dividend of $0.34 per share. The ex-dividend date was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a yield of 0.97%. Teleflex's dividend payout ratio is presently 95.77%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.